Multiple Myeloma Patients Achieve Clinical Remission in Early CAR T-Cell Therapy Trial – Specialty Pharmacy Times
|
Multiple Myeloma Patients Achieve Clinical Remission in Early CAR T-Cell Therapy Trial
Specialty Pharmacy Times Ninety-four percent of patients with multiple myeloma achieved clinical remission after receiving chimeric antigen receptor (CAR) T-cell therapy that targeted B-cell maturation protein (BMCA). Although prior studies show that CAR T-cell therapy … |
